Added to YB: 2026-01-21
Pitch date: 2026-01-19
RMTI [neutral]
Rockwell Medical, Inc.
-9.01%
current return
Author Info
Byron Street Research is an investment publication featuring a weekly event-driven idea generator, write-ups modeled in the familiar format of sell-side equity research reports, and performance reviews structured as traditional fund factsheets. Sign up for the newsletter.
Company Info
Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide.
Market Cap
$37.7M
Pitch Price
$1.11
Price Target
N/A
Dividend
N/A
EV/EBITDA
-113.56
P/E
-5.51
EV/Sales
0.36
Sector
Health Care Equipment and Supplies
Category
growth
Catalyst Watch - Rockwell Medical, Inc.
RMTI (update): Added 30 new West Coast customers generating multi-million revenue, leveraging hemodialysis supply chain disruptions where supplier options limited. West Coast now >10% of clinic footprint. New customers include large non-profit healthcare system & innovative renal care centers.
Read full article (1 min)